Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Glioblastoma 14Brain Neoplasms 11Gliosarcoma 8Glioma 7Oligodendroglioma 5Central Nervous System Neoplasms 5Astrocytoma 5Neoplasm Metastasis 4Neuroblastoma 3Breast Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Pinealoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Pheochromocytoma 1Pharyngeal Neoplasms 1Paraganglioma, Extra-Adrenal 1Pancreatic Neoplasms 1Osteosarcoma 1Neurofibromatosis 2 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Neoplasms, Mesothelial 1

Interventions

Temozolomide 6Cyclophosphamide 5Magnetic Resonance Spectroscopy 4Carboplatin 4etoposide phosphate 3Thiotepa 3Surgical Procedures, Operative 3Irinotecan 3Filgrastim 3Automobiles 3temsirolimus 2fludarabine 2entinostat 2Vincristine 2Radiotherapy, Conformal 2Proton Therapy 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Isotretinoin 2Granulocyte Colony-Stimulating Factor 2Gadolinium DTPA 2Etoposide 2Donepezil 2Cisplatin 2Celecoxib 2Bevacizumab 2Amplified Fragment Length Polymorphism Analysis 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trametinib 1tozuleristide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pinealoma × temsirolimus × CNS × Clear all
NCT00784914 2018-04-17

A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

City of Hope Medical Center

Phase 1 Completed
12 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasm Metastasis, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

NCT01182883 2017-07-02

A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn
CNS

Glioma, Pinealoma, Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡